UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$155M |
| 2 |
Wells Fargo
WFC
|
+$134M |
| 3 |
Biogen
BIIB
|
+$121M |
| 4 |
Alibaba
BABA
|
+$108M |
| 5 |
Delta Air Lines
DAL
|
+$107M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Scotiabank
BNS
|
+$255M |
| 2 |
Chevron
CVX
|
+$220M |
| 3 |
Bank of Montreal
BMO
|
+$192M |
| 4 |
Canadian Imperial Bank of Commerce
CM
|
+$191M |
| 5 |
Enbridge
ENB
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.93% |
| 2 | Financials | 14.16% |
| 3 | Healthcare | 13.87% |
| 4 | Consumer Discretionary | 11.78% |
| 5 | Industrials | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Comcast
CMCSA
$85.8B
| $850M | 0.63% |
24,000,848
+1,203,599
| +5% | +$42.6M |
|
27
AT&T
T
$169B
| $837M | 0.62% |
32,999,278
-1,215,229
| -4% | -$29.8M |
|
28
Walt Disney
DIS
$172B
| $801M | 0.6% |
6,850,980
+722,406
| +12% | +$80.4M |
|
29
Verizon
VZ
$201B
| $773M | 0.57% |
14,474,925
+205,972
| +1% | +$10.9M |
|
30
NVIDIA
NVDA
$4.77T
| $768M | 0.57% |
109,297,680
+9,792,120
| +10% | +$63.7M |
|
|
31
Chevron
CVX
$374B
| $748M | 0.56% |
6,113,535
-1,810,926
| -23% | -$220M |
|
32
Boeing
BA
$175B
| $739M | 0.55% |
1,986,771
-17,011
| -0.8% | -$5.98M |
|
33
TJX Companies
TJX
$178B
| $685M | 0.51% |
12,224,660
-1,722,334
| -12% | -$88.5M |
|
34
Merck
MRK
$326B
| $642M | 0.48% |
9,485,782
-95,625
| -1% | -$6.09M |
|
35
IBM
IBM
$214B
| $638M | 0.47% |
4,413,637
+32,117
| +0.7% | +$4.49M |
|
36
Coca-Cola
KO
$380B
| $625M | 0.46% |
13,527,786
-34,066
| -0.3% | -$1.56M |
|
37
American Express
AXP
$227B
| $622M | 0.46% |
5,844,892
+545,177
| +10% | +$56.7M |
|
38
Abbott
ABT
$187B
| $616M | 0.46% |
8,394,848
-149,338
| -2% | -$9.81M |
|
39
Oracle
ORCL
$346B
| $578M | 0.43% |
11,203,043
-332,977
| -3% | -$16.2M |
|
40
Union Pacific
UNP
$175B
| $574M | 0.43% |
3,526,327
-95,130
| -3% | -$14.3M |
|
41
Citigroup
C
$222B
| $569M | 0.42% |
7,926,396
-150,977
| -2% | -$10.7M |
|
42
Amgen
AMGN
$212B
| $552M | 0.41% |
2,663,948
-114,054
| -4% | -$22.5M |
|
|
AGN
43
DELISTED
Allergan plc
AGN
| $551M | 0.41% |
2,894,528
+842,647
| +41% | +$155M |
|
44
Elevance Health
ELV
$83.7B
| $546M | 0.41% |
1,991,659
-169,260
| -8% | -$43.9M |
|
45
Accenture
ACN
$101B
| $544M | 0.4% |
3,196,806
+172,463
| +6% | +$28.7M |
|
46
Nike
NKE
$63.9B
| $542M | 0.4% |
6,402,504
+48,429
| +0.8% | +$3.89M |
|
47
AbbVie
ABBV
$465B
| $529M | 0.39% |
5,595,489
-43,583
| -0.8% | -$4.13M |
|
|
48
Biogen
BIIB
$30.4B
| $513M | 0.38% |
1,452,894
+351,238
| +32% | +$121M |
|
49
Thermo Fisher Scientific
TMO
$214B
| $511M | 0.38% |
2,093,017
+24,301
| +1% | +$5.59M |
|
50
Broadcom
AVGO
$1.81T
| $511M | 0.38% |
20,704,540
+3,195,370
| +18% | +$71.7M |
|
Similar funds
UBS AM's Q3 2018 Portfolio in Review
As of Q3 2018, UBS AM held 2,869 positions worth $135B, up 3.1% from $130B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS AM's Q3 2018 filing shows 86 new, 1,174 increased, 804 reduced and 106 closed positions. Its largest new stake was Athene Holding Ltd. Class A Common Shares: 1,079,023 shares worth $55.7M. The largest sale was Scotiabank, an estimated $255M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
- UBS AM's largest Q3 2018 buy was Athene Holding Ltd. Class A Common Shares: 1,079,023 shares worth $55.7M.
- UBS AM added most to Allergan plc in Q3 2018, an estimated $155M increase.
- UBS AM's biggest Q3 2018 reduction was Scotiabank, cutting an estimated $255M.
- UBS AM fully exited BCE in Q3 2018, selling an estimated $35M.
- UBS AM's ten largest holdings make up 18% of its $135B portfolio in Q3 2018.
- UBS AM opened 86 new positions and closed 106 in Q3 2018.
- UBS AM's portfolio value rose 3.1% quarter-over-quarter to $135B.
Based on UBS AM's 13F filing for Q3 2018, filed 14 Nov 2018.